Catalyst
Slingshot members are tracking this event:
MediciNova receives receipt from the European Patent Office of a notice of intent to allow patent for MN-029 (denibulin) di-hydrochloride
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MNOV |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 13, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Patent Office, Mn-029, Denibulin, Di-hydrochloride
